a:5:{s:8:"template";s:12592:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<title>{{ keyword }}</title>
<meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
<meta content="width=device-width,initial-scale=1.0" name="viewport"/>
<link href="http://fonts.googleapis.com/css?family=Yanone+Kaffeesatz:400,700" rel="stylesheet" type="text/css"/>
<link href="http://fonts.googleapis.com/css?family=Oswald" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css">@charset "utf-8";body,div,footer,form,h1,h2,h3,header,html,img,li,nav,p,span,time,ul{margin:0;padding:0;border:0;outline:0;font-size:100%;vertical-align:baseline;background:0 0}body{line-height:1}footer,header,nav{display:block}nav ul{list-style:none}a{margin:0;padding:0;font-size:100%;vertical-align:baseline;background:0 0}a{margin:0;padding:0;font-size:100%;vertical-align:baseline;background:0 0}input{vertical-align:middle}#sb-site,.sb-slidebar,body,html{margin:0;padding:0;-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}body,html{width:100%;overflow-x:hidden}html{height:100%}body{min-height:100%;height:auto;position:relative}#sb-site{width:100%;position:relative;z-index:1}.sb-slidebar{height:100%;overflow-y:auto;position:fixed;top:0;z-index:0;display:none;background-color:#fff;-webkit-transform:translate(0)}.sb-right{right:0}.sb-slidebar{width:30%}@media (max-width:480px){.sb-slidebar{width:70%}}@media (min-width:481px){.sb-slidebar{width:55%}}@media (min-width:768px){.sb-slidebar{width:40%}}@media (min-width:992px){.sb-slidebar{width:30%}}@media (min-width:1200px){.sb-slidebar{width:20%}}#sb-site,.sb-slidebar{-webkit-transition:-webkit-transform .4s ease;-moz-transition:-moz-transform .4s ease;-o-transition:-o-transform .4s ease;transition:transform .4s ease;-webkit-transition-property:-webkit-transform,left,right;-webkit-backface-visibility:hidden} @font-face{font-family:'Yanone Kaffeesatz';font-style:normal;font-weight:700;src:url(http://fonts.gstatic.com/s/yanonekaffeesatz/v14/3y9I6aknfjLm_3lMKjiMgmUUYBs04aUXNxt9gW2LIftoEdKZd2GP.ttf) format('truetype')}body{margin:0;font-family:'Century Gothic',Helvetica,Arial,Sans-serif;font-size:14px;line-height:20px;text-align:left;vertical-align:top;background:#fff;color:#000}body,form,h1,h2,h3,p{margin:0;padding:0}h1{font-size:24px;padding:0 0 10px 0}a:link,a:visited{text-decoration:none;color:#ef717d}a:hover{color:#f28b2e}p{padding:0 0 10px}.clear{clear:both}#sb-site{}#wrapper{background:#fff;margin:0 auto 0 auto;max-width:1000px;text-align:left;width:100%}#innerWrap{padding:0 30px;width:auto}#mainHd{min-height:163px;width:100%}#mainHd h1{float:left;height:163px;margin:0;text-indent:-9999px;width:234px}#mainHd h1 a{display:block;height:163px;width:234px}#mainHd .menu{border-top:6px double #999b9a;border-bottom:6px double #999b9a;float:right;font-family:'Yanone Kaffeesatz';font-size:44px;font-weight:700;line-height:44px;list-style:none;margin:25px 0 10px;padding:5px 0;max-width:706px;text-transform:uppercase;width:auto}#mainHd .menu li{float:left;list-style:none;position:relative}#mainHd .menu li a{padding:0 12px}#mainHd .menu li ul{display:none;position:absolute;top:44px;left:0;width:180px;background:#fff;box-shadow:0 0 4px #606060;z-index:99}#mainHd .menu li:hover ul{display:block}#mainHd .menu li ul li{float:none;font-size:24px;line-height:24px;margin:0;padding:0}#mainHd .menu li ul li a{display:block;padding:10px 0 10px 15px}#mainHd .menu li:nth-child(6n-5) a{color:#ef7163}#mainHd .menu li:nth-child(6n-5) a:hover{color:#999b9a}#mainHd .menu li:nth-child(6n-4) a,#mainHd .menu li:nth-child(6n-4) ul li a{color:#ef717d}#mainHd .menu li:nth-child(6n-4) a:hover,#mainHd .menu li:nth-child(6n-4) ul li a:hover{color:#999b9a}#mainHd .menu li:nth-child(6n-3) a{color:#f49081}#mainHd .menu li:nth-child(6n-3) a:hover{color:#999b9a}#mainHd .menu li:nth-child(6n-2) a{color:#f28b2e}#mainHd .menu li:nth-child(6n-2) a:hover{color:#999b9a}#mainHd .menu li:nth-child(6n-1) a{color:#fac829}#mainHd .menu li:nth-child(6n-1) a:hover{color:#999b9a}  .menu{border-top:1px solid #ccc;clear:both;font-family:'Yanone Kaffeesatz';font-size:30px;font-weight:700;line-height:30px;list-style:none;padding-top:5px;text-align:right;text-transform:uppercase}.sb-slidebar .menu li{border-bottom:1px solid #ccc;padding:0 0 5px;margin-bottom:5px}.sb-slidebar .menu ul{list-style:none;padding-top:5px}.sb-slidebar .menu ul li{border-bottom:none;font-size:24px;line-height:24px;padding:0 0 0;font-weight:400}.sb-slidebar .menu ul li a{color:#7bd3c7}.sb-slidebar .menu ul li a:hover{color:#5fbbb6}.sb-toggle-right{display:none;cursor:pointer;float:right;margin:0;padding-top:30px;width:25px}.sb-toggle-right .navicon-line{background:#ef717d;display:block;height:5px;margin:0 auto 5px;width:25px}.sb-toggle-right:hover .navicon-line{background:#5fbbb6}#mainFoot{background:#f49081;box-sizing:border-box;clear:both;color:#fff;padding:30px 2% 0 2%;width:100%}#leftFt{box-sizing:border-box;float:left;max-width:470px;padding-right:15px;width:50%}#leftFt #ftNav .menu{color:#fff;list-style:none;float:left;border-top:6px double #fff;border-bottom:6px double #fff;font-family:'Yanone Kaffeesatz';font-size:22px;font-weight:700;line-height:22px;padding:5px 0;margin-bottom:15px;text-transform:uppercase;width:100%}#leftFt #ftNav .menu li{float:left;padding:2px 5px 2px 0;border-right:3px solid #fff;margin-right:5px}#leftFt #ftNav .menu li:last-child{padding-right:0;border-right:none;margin-right:0}#leftFt #ftNav .menu li a{color:#fff}#leftFt #ftNav .menu li a:hover{color:#f8d4cf}#leftFt .socialIcons{color:#f8d4cf;font-family:'Yanone Kaffeesatz';font-size:28px;font-weight:700;line-height:28px;list-style:none;float:left;height:33px;text-transform:uppercase;vertical-align:bottom;width:410px}#leftFt .socialIcons::before{content:"DON'T BE ANTI-SOCIAL:"}#leftFt .socialIcons li a{background-position:center bottom;background-repeat:no-repeat;display:block;height:32px;width:32px}#leftFt .socialIcons li a:hover{background-position:center top}#rightFt{box-sizing:border-box;float:right;max-width:470px;padding-left:15px;width:50%}#rightFt::after{clear:both}#rightFt #bioPic{box-sizing:border-box;float:right;height:169px;margin:0 0 10px 15px;padding:5px;width:147px}#rightFt #bioPic img{height:auto;max-width:100%}#rightFt h3{color:#fff;font-family:havana;font-size:57px;font-weight:400;line-height:57px}#rightFt h3 span{color:#fac829}#mainFoot p{line-height:18px}p.copy{clear:both;color:#fff;font-size:10px;line-height:12px;margin:0;padding:10px 0 0}.copy a{color:#606060}.copy a:hover{color:#fff}#slider{margin-bottom:30px}#recBlog{background:#f7f5ef box-sizing:border-box;padding:20px 20px 40px;margin-bottom:20px;float:right;min-height:272px;width:74%}#recBlog h2{color:#ef717d;font-family:'Yanone Kaffeesatz';font-size:34px;font-weight:700;line-height:34px;margin:0 0 5px;padding:0;text-transform:uppercase;width:100%}#recBlog p.date{font-size:12px;line-height:16px}#recBlog .more{color:#fff;float:right;font-family:'Yanone Kaffeesatz';font-size:26px;font-weight:700;line-height:26px;text-transform:uppercase}#recBlog .more a{background:#ef717d;color:#fff;display:block;padding:5px 10px;width:auto}#recBlog .more a:hover{background:#f28b2e}#newsletter{background:#ef717d;box-sizing:border-box;color:#fff;float:left;margin-bottom:20px;padding:20px 20px 50px;width:24%}#newsletter h2{font-family:havana;font-size:48px;font-weight:400;line-height:48px;margin:0;padding:0}#newsletter h3{font-family:'Yanone Kaffeesatz';font-size:24px;line-height:24px;margin:0 0 15px;text-align:right;text-transform:uppercase}#newsletter input[type=email],#newsletter input[type=text]{background:#f799a2;border:none;box-sizing:border-box;height:32px;margin-bottom:10px;padding:5px 10px;width:100%}#newsletter input[type=submit]{background:#fac829;border:none;color:#fff;font-family:'Yanone Kaffeesatz';font-size:26px;font-weight:700;float:right;letter-spacing:normal;line-height:26px;padding:5px 10px;text-transform:uppercase;width:auto}#newsletter input[type=submit]:hover{background:#b1e2dc}#pco,#shco{box-sizing:border-box;float:left;padding-bottom:40px;width:50%}#pco{padding-right:10px}#pco h3{border-top:6px double #999b9a;border-bottom:6px double #999b9a;color:#f28b2e;font-family:'Yanone Kaffeesatz';font-family:havana;font-size:44px;font-weight:400;line-height:44px;margin:0 0 15px;padding:5px 0;text-align:center;width:100%}#shco{padding-left:10px}#shco h3{border-top:6px double #999b9a;border-bottom:6px double #999b9a;color:#5fbbb6;font-family:havana;font-size:44px;font-weight:400;line-height:44px;margin:0 0 15px;padding:5px 0;text-align:center;width:100%}.releaseBlock{box-sizing:border-box;max-width:320px;float:left;height:auto;margin:0;padding:10px;width:50%}.releaseBlock img{height:auto;max-width:100%}input[type=email]{background:#d8d8d8;border:none;box-sizing:border-box;height:40px;margin:0 0 15px;padding:10px 15px;width:100%}::-webkit-input-placeholder{color:#fff}:-moz-placeholder{color:#fff}::-moz-placeholder{color:#fff}:-ms-input-placeholder{color:#fff}.rslides{box-sizing:border-box;position:relative;list-style:none;width:100%;padding:0;margin:0;z-index:0}.rslides li{-webkit-backface-visibility:hidden;position:absolute;display:none;width:100%;left:0;top:0;z-index:0}.rslides li:first-child{position:relative;display:block;float:left}.rslides img{display:block;height:auto;float:left;width:100%;border:0}@media screen and (max-width:960px){#sb-site{background:#fff}#wrapper{padding:0;width:100%}#innerWrap{padding:0 5%;width:90%}#mainHd .menu{font-size:30px;line-height:30px}}@media screen and (max-width:865px){#mainHd{margin-bottom:20px}#mainHd h1{float:none;margin:0 auto}#mainHd .menu{float:left;font-size:44px;line-height:44px;margin:10px auto;max-width:100%;width:100%}#mainHd .menu li:last-child::after{clear:both}#mainHd .socialIcons{padding:0}}@media screen and (max-width:768px){#mainHd h1{float:left;margin:0}#mainHd #searchform,#mainHd .menu,#mainHd .socialIcons{display:none}.sb-toggle-right{display:block}#leftFt .socialIcons{display:none}#leftFt,#rightFt{float:none;margin:0 auto 20px;width:100%;max-width:100%}#newsletter,#recBlog{width:48%}#pco h3,#shco h3{font-size:30px;line-height:30px}.releaseBlock{float:none;margin:0 auto;width:100%}}@media screen and (max-width:480px){#newsletter,#recBlog{float:none;width:100%}#pco,#shco{float:none;padding:0 0 30px;width:100%}}@media only screen and (-webkit-min-device-pixel-ratio:2),only screen and (min--moz-device-pixel-ratio:2),only screen and (-o-min-device-pixel-ratio:2/1),only screen and (min-device-pixel-ratio:2){#mainHd h1{-webkit-background-size:234px 163px;-moz-background-size:234px 163px;-o-background-size:234px 163px;background-size:234px 163px} @font-face{font-family:Oswald;font-style:normal;font-weight:400;src:url(http://fonts.gstatic.com/s/oswald/v31/TK3_WkUHHAIjg75cFRf3bXL8LICs1_FvsUZiYA.ttf) format('truetype')}}</style>
</head>
<body>
<div id="sb-site">
<div id="wrapper">
<div id="innerWrap">
<header id="mainHd">
<h1>{{ keyword }}</h1>
<ul class="menu" id="menu-main-navigation-menu">
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-home menu-item-1995" id="menu-item-1995"><a href="#">{{ keyword }}</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page current_page_parent menu-item-1994" id="menu-item-1994"><a href="#">Blog</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-1998" id="menu-item-1998"><a href="#">About</a></li>
<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-1999" id="menu-item-1999"><a href="#">Tutorials</a></li>
</ul>
<div class="clear"></div>
</header>
{{ text }}
<p>.</p>
{{ links }}
</div>
<footer id="mainFoot">
<div id="leftFt">
<nav id="ftNav">
<ul class="menu" id="menu-footer-navigation-menu">
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2025" id="menu-item-2025"><a href="#">Terms of Use</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2015" id="menu-item-2015"><a href="#">Contact</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2027" id="menu-item-2027"><a href="#">Info</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2014" id="menu-item-2014"><a href="#">Additional Services</a></li>
</ul> </nav>
<div class="clear"></div>
<p class="copy">{{ keyword }}</p>
</div>
<div id="rightFt">
<div id="bioPic"></div>
<h3>{{ keyword }}</h3>
</div>
<div class="clear"></div>
</footer>
</div>
</div>
</body>
</html>";s:4:"text";s:7231:"<br>[4]  Although this use is common in UK clinical practice, at the time of publication (February 2015), gemcitabine in combination with paclitaxel did not have a UK marketing authorisation for this indication. 1.3.12 
 
 1.6.2 After radical cystectomy consider using a follow‑up protocol that consists of: monitoring of the upper tracts for hydronephrosis, stones and cancer using imaging and glomerular filtration rate (GFR) estimation at least annually and, monitoring for local and distant recurrence using CT of the abdomen, pelvis and chest, carried out together with other planned CT imaging if possible, 6, 12 and 24 months after radical cystectomy and, monitoring for metabolic acidosis and B12 and folate deficiency at least annually and. This guideline covers diagnosing and managing bladder cancer in people 18 and above referred from primary care with suspected bladder cancer, and those with newly diagnosed or recurrent bladder (urothelial carcinoma, adenocarcinoma, squamous-cell carcinoma or small-cell carcinoma) or urethral cancer. All problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the Yellow Card Scheme.                  Discuss with the person: the type, stage and grade of their cancer and likely prognosis, the potential complications of intrusive procedures, including urinary retention, urinary infection, pain, bleeding or need for a catheter, the impact of treatment on their sexual health and body image, including how to find support and information relevant to their gender, diet and lifestyle, including physical activity, how to find information about bladder cancer, for example through information prescriptions, sources of written information, websites or DVDs, how to find support groups and survivorship programmes, how to find information about returning to work after treatment for cancer. Numerator – the number in the denominator who have a discussion about intravesical BCG and radical cystectomy with a urologist who performs both treatments and a clinical nurse specialist before agreeing a treatment option. Ensure that the choice is based on a full discussion between the person and a urologist who performs radical cystectomy, a clinical oncologist and a clinical nurse specialist. <br> <br>This is in line with what NICE normally considers acceptable for end-of-life treatments (less than £50,000 per QALY gained), although other plausible estimates are higher. To make clear recommendations for management, the Guideline Development Group developed the consensus classification in the table below, based on the evidence reviewed and clinical opinion. [2013] 1.4.34 The use of desmopressin may be considered specifically to reduce nocturia in women with urinary incontinence or overactive bladder who find it a troublesome symptom. Published by American Urological Association, 01 May 2014. Results for NICE guidelines in bladder and bowel dysfunction 1 - 10 of 180 sorted by relevance / date. 1.2.10 Consider CT urography, carried out with other planned CT imaging if possible, to detect upper tract involvement in people with new or recurrent high‑risk non‑muscle‑invasive or muscle‑invasive bladder cancer. (Also see the NICE Pathway on bladder cancer for other technology appraisals on this topic.). Everything NICE has said on bladder cancer in adults in an interactive flowchart. Adults with bladder cancer have access to a designated clinical nurse specialist. Published by European Association of Urology Nurses (EAUN), 01 March 2015. development of an individualised toileting schedule, which pre‐empts involuntary bladder emptying. Ensure that the person has an opportunity to discuss the risks and benefits with an oncologist who treats bladder cancer. 1.2.1 
 View all similar results, Ureteral stenosis • Pancreatitis • Liver failure • Gall-bladder dysfunction • Ileus • Inflammatory bowel disease • Hypotension, Published by NHS resolution, 11 October 2012. looked at: stillbirth or death during birth admission to a neonatal special care unit need for resuscitation poor health score (Apgar... Click export CSV or RIS to download the entire page or use the checkbox in each result to select a subset of records to download. Published by Multidisciplinary Association of Spinal Cord, 01 September 2012. Evidence from 2 clinical trials, one of which compares atezolizumab directly with chemotherapy, suggests that atezolizumab is an effective treatment. Discharging adults who have had low-risk non-muscle-invasive bladder cancer and who have no recurrence of the bladder cancer within 12 months to primary care reduces the need for follow-up cystoscopies in secondary care. However, the cost-effectiveness estimates assume that, despite a 2-year stopping rule, the effect of pembrolizumab continues for the duration of the model (a lifetime continued treatment effect) which is implausible.         
 Proportion of TURBT procedures during which detrusor muscle was obtained. <br> <br>the limited evidence about whether surgery or radiotherapy with a radiosensitiser is the most effective cancer treatment. 1.1.6 Offer smoking cessation support to all people with bladder cancer who smoke, in line with NICE's guideline on stop smoking interventions and services. This guideline covers when to offer caesarean section, procedural aspects of the operation and care after caesarean section. 1.5.6 Offer people with bladder cancer and, if they wish, their partners, families or carers, opportunities to have discussions with a stoma care nurse before and after radical cystectomy as needed.                 Sort by Date. These quality statements are taken from the. Showing results 1 to 10. 1.3.9 For people in whom induction BCG has failed, the specialist urology multidisciplinary team should assess the suitability of radical cystectomy, or further intravesical therapy if radical cystectomy is unsuitable or declined by the person, or if the bladder cancer that recurs is intermediate‑ or low‑risk.  Record the size and number of tumours during TURBT. <br> <br>                 The prescriber should follow relevant professional guidance, taking full responsibility for the decision. <br> <br>            . Review the evidence across broad health and social care topics. surgical procedures for stress urinary incontinence. Also, the long-term benefits of pembrolizumab are uncertain because the trial is ongoing. The clinical nurse specialist can be involved in discussing treatment options and act as the person’s key worker to address their information and care needs, including psychosocial support and referral to palliative care if needed. Offer follow-up after radical cystectomy or radical radiotherapy. 1.5.7 Consider adjuvant cisplatin combination chemotherapy after radical cystectomy for people with a diagnosis of muscle‑invasive or lymph‑node‑positive urothelial bladder cancer for whom neoadjuvant chemotherapy was not suitable (because muscle invasion was not shown on biopsies before cystectomy). Published by European Association of Urology (EAU), 30 March 2014. <br>";s:7:"keyword";s:23:"nice guidelines bladder";s:5:"links";s:2626:"<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-will-ferrell-coffee'>Will Ferrell Coffee</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-palau-hotels-sardinia'>Palau Hotels Sardinia</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-nickolas-grace-robin-of-sherwood'>Nickolas Grace Robin Of Sherwood</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-japan-results'>Japan Results</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-2010-and-2014-world-cup'>2010 And 2014 World Cup</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-usda-nop-handbook'>Usda Nop Handbook</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-where-to-buy-belhaven-beer-near-me'>Where To Buy Belhaven Beer Near Me</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-bundeswehr-meaning'>Bundeswehr Meaning</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-carrie-underwood-and-mike-fisher-i-am-second'>Carrie Underwood And Mike Fisher I Am Second</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-fiji-national-football-team-matches'>Fiji National Football Team Matches</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-iran-and-italy-genetics'>Iran And Italy Genetics</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-he-jiankui-missing'>He Jiankui Missing</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-vacation-planning-services'>Vacation Planning Services</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-australia-minimum-wage-in-usd'>Australia Minimum Wage In Usd</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-resource-crunch-meaning'>Resource Crunch Meaning</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-stir-crazy-wok'>Stir Crazy Wok</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-wage-and-hour-violations-penalties'>Wage And Hour Violations Penalties</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-crispr-blindness-trials'>Crispr Blindness Trials</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-beverly-hills%2C-90210-season-1-episode-4'>Beverly Hills, 90210 Season 1 Episode 4</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-agatha-christie%27s-poirot-season-1-episode-9'>Agatha Christie's Poirot Season 1 Episode 9</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-when-did-spain-lose-morocco'>When Did Spain Lose Morocco</a>,
";s:7:"expired";i:-1;}